Shigella Conjugate Vaccine from Germany
Polysaccharide-protein conjugate vaccine targeting Shigella flexneri for diarrheal disease prophylaxis. Classified in HTS 3002.49.0050 as other immunological product from microbial cultures, modified biotechnologically for therapeutic use.
Duty Rate — Germany → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Include conjugate linkage details in specs; FDA biologics surveillance applies
• Certify sterility and adjuvant absence if applicable; use insulated shippers